Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
NACLC 2019
2019 North American Conference on Lung Cancer
(Chicago, IL, USA): October 10 – 12, 2019
The NACLC 2019 Virtual Meeting will be composed of the PowerPoint slides of the presentations only.Presentation Date(s):- October 10 – 12, 2019
- Total Presentations: 125
-
+
GS01 - Opening & Keynote Lectures
- Type: Invited Speaker Session
- Track:
- Presentations: 7
- Slides Available
- Coordinates: 10/10/2019, 18:00 - 19:30, Rouge (Lobby Level)
-
+
GS01.01 - Welcome
18:00 - 18:05 | Author(s): Everett Vokes
- Abstract
No abstract available for this presentation
-
+
GS01.02 - Welcome from the IASLC President Elect
18:05 - 18:10 | Presenter: Heather Wakelee
- Abstract
No abstract available for this presentation
-
+
GS01.03 - Screening
18:10 - 18:30 | Presenter: Claudia Henschke
- Abstract
No abstract available for this presentation
-
+
GS01.04 - Q&A
18:30 - 18:35
- Abstract
No abstract available for this presentation
-
+
GS01.05 - Disparities in Screening (Slides Available)
18:35 - 18:55 | Presenter: M. Patricia Rivera
- Abstract
No abstract available for this presentation
-
+
GS01.06 - Q&A
18:55 - 19:00
- Abstract
No abstract available for this presentation
-
+
GS01.07 - IO + Chemo vs IO Alone in PD-L1 1-49% and PD-L1 50% (Slides Available)
20:00 - 20:20 | Author(s): Ramaswamy Govindan
- Abstract
No abstract available for this presentation
-
+
GS02 - Prevention, Early Detection and Patient Provider Partnerships
- Type: Invited Speaker Session
- Track:
- Presentations: 9
- Slides Available
- Coordinates: 10/11/2019, 08:05 - 09:45, Imperial Ballroom (B2 Level)
-
+
GS02.01 - Welcome and Travel Award Presentations
08:05 - 08:10
- Abstract
No abstract available for this presentation
-
+
GS02.02 - Clinical Trial Shaping Our Next Step - Partnership between Investigators and Patients (Slides Available)
08:10 - 08:25 | Presenter: Karen Kelly
- Abstract
No abstract available for this presentation
-
+
GS02.03 - Electronic Cigarettes and Vaping (Slides Available)
08:25 - 08:35 | Presenter: Anthony Alberg
- Abstract
No abstract available for this presentation
-
+
GS02.04 - Imaging to Identify and Characterize Lung Nodules (Slides Available)
08:35 - 08:50 | Author(s): Herbert MacMahon
- Abstract
No abstract available for this presentation
-
+
GS02.05 - Molecular Biomarkers in Early Detection of Lung Cancer
08:50 - 09:00 | Presenter: Peter Mazzone
- Abstract
No abstract available for this presentation
-
+
GS02.06 - How Lung Cancer Advocacy and Research Has Changed in the Past Years (Slides Available)
09:00 - 09:10 | Presenter: Jill Feldman
- Abstract
No abstract available for this presentation
-
+
GS02.07 - The Increasing Importance of Social Media in Advocacy (Slides Available)
09:10 - 09:20 | Presenter: Brendon Stiles
- Abstract
No abstract available for this presentation
-
+
GS02.08 - Financial Toxicity of Cancer Therapy
09:20 - 09:30 | Author(s): Fumiko Chino
- Abstract
No abstract available for this presentation
-
+
GS02.09 - Panel Discussion
09:30 - 09:45
- Abstract
No abstract available for this presentation
-
+
GS03 - Biomarkers in 2019 and Beyond
- Type: Invited Speaker Session
- Track:
- Presentations: 6
- Slides Available
- Coordinates: 10/11/2019, 10:15 - 11:15, Imperial Ballroom (B2 Level)
-
+
GS03.01 - Introduction
10:15 - 10:20 | Presenter: Charu Aggarwal
- Abstract
No abstract available for this presentation
-
+
GS03.02 - Innovations in Broad Sequencing Including Fusion Detection and Cellularity Constraints (Slides Available)
10:20 - 10:30 | Presenter: Marc Ladanyi
- Abstract
No abstract available for this presentation
-
+
GS03.03 - TMB Ready for Prime Time? (Slides Available)
10:30 - 10:40 | Presenter: John Longshore
- Abstract
No abstract available for this presentation
-
+
GS03.04 - Incorporating Blood Biomarkers into Clinical Practice (Slides Available)
10:40 - 10:50 | Presenter: Charu Aggarwal
- Abstract
No abstract available for this presentation
-
+
GS03.05 - Genomic Biomarkers of Immunotherapy Sensitivity and Resistance (Slides Available)
10:50 - 11:00 | Presenter: Ferdinandos Skoulidis
- Abstract
No abstract available for this presentation
-
+
GS03.06 - Panel Discussion
11:00 - 11:15
- Abstract
No abstract available for this presentation
-
+
GS04 - Patient Selection for Local Therapies in the Era of Immunotherapy
- Type: Invited Speaker Session
- Track:
- Presentations: 7
- Slides Available
- Coordinates: 10/11/2019, 10:15 - 11:15, Rouge (Lobby Level)
-
+
GS04.01 - Introduction
10:15 - 10:20 | Presenter: Jessica Donington
- Abstract
No abstract available for this presentation
-
+
GS04.02 - Pre-habilitation/Patient Selection and Enhanced Recovery after Surgery (ERAS) (Slides Available)
10:20 - 10:28 | Author(s): Katerine Kuhns
- Abstract
No abstract available for this presentation
-
+
GS04.03 - Induction Strategies for Stage II/IIIA NSCLC including Radiation and IO (Slides Available)
10:28 - 10:36 | Presenter: Jessica Donington
- Abstract
No abstract available for this presentation
-
+
GS04.04 - Role of IO and SBRT for Inoperable Early Stage NCLC (Slides Available)
10:36 - 10:44 | Presenter: Clifford Robinson
- Abstract
No abstract available for this presentation
-
+
GS04.05 - Recurrence after SBRT (Slides Available)
10:44 - 10:52 | Presenter: Mara B. Antonoff
- Abstract
No abstract available for this presentation
-
+
GS04.06 - Assessment and Management of IO Toxicity in Combined Modality Trials (Slides Available)
10:52 - 11:00 | Presenter: Mary Fidler
- Abstract
No abstract available for this presentation
-
+
GS04.07 - Panel Discussion
11:00 - 11:15
- Abstract
No abstract available for this presentation
-
+
GS05 - Keynote: NCI Perspectives: Lung Cancer Initiatives
- Type: Invited Speaker Session
- Track:
- Presentations: 2
- Coordinates: 10/11/2019, 12:45 - 13:45, Imperial Ballroom (B2 Level)
-
+
GS05.01 - Introduction
12:45 - 12:50 | Presenter: Everett Vokes
- Abstract
No abstract available for this presentation
-
+
GS05.02 - Keynote: NCI Perspectives: Lung Cancer Initiatives
12:50 - 13:35 | Presenter: Douglas Lowy
- Abstract
No abstract available for this presentation
-
+
OA01 - Precision Medicine and Personalized Therapy for Lung Cancer
- Type: Oral Abstract Session
- Track:
- Presentations: 11
- Slides Available
- Coordinates: 10/11/2019, 14:00 - 15:40, Imperial Ballroom (B2 Level)
-
+
OA01.01 - Pembrolizumab Plus Chemotherapy For Advanced NSCLC Without Tumor PD-L1 Expression: Pooled Analysis of KN021G, KN189 and KN407 (Slides Available)
15:00 - 15:07 | Presenter: Hossein Borghaei
- Abstract
Loading... -
+
OA01.02 - Prognostic Value of Baseline Autoantibodies in Metastatic NSCLC Patients Receiving PD-/PDL-1 Targeted Immunotherapy (Slides Available)
14:07 - 14:14 | Presenter: Imad Tarhoni
- Abstract
Loading... -
+
OA01.03 - Prognostic Role of NLR in Stage III NSCLC Undergoing Chemoradiation: Secondary Analysis of PROCLAIM Trial (Slides Available)
14:14 - 14:21 | Presenter: tithi biswas
- Abstract
Loading... -
+
OA01.04 - Safety and Efficacy of Flu Vaccination after Treatment with Immune Checkpoint Inhibitors: A Retrospective Review (Slides Available)
15:21 - 15:28 | Presenter: Nathan Roberts
- Abstract
Loading... -
+
OA01.05 - Discussant: IO Prognostics Beyond PD-L1 and TMB (Slides Available)
14:00 - 15:40 | Presenter: Nasser Hanna
- Abstract
No abstract available for this presentation
-
+
OA01.06 - Safety, Efficacy, and Pharmacokinetics of AMG 510, a Novel KRASG12C Inhibitor, in Patients with Non-Small Cell Lung Cancer (Slides Available)
14:38 - 14:43 | Author(s): Ramaswamy Govindan
- Abstract
Loading... -
+
OA01.07 - Capmatinib (INC280) in METΔex14-mutated Advanced NSCLC: Efficacy Data from the Phase 2 GEOMETRY Mono-1 Study (Slides Available)
15:43 - 15:48 | Presenter: Rebecca S. Heist
- Abstract
Loading... -
+
OA01.08 - A Phase I Study to Evaluate Safety and Antitumor Activity of BPI-7711 in EGFRm+/T790M+ Advanced or Recurrent NSCLC Patients (Slides Available)
14:48 - 14:53 | Presenter: Yuankai Shi
- Abstract
Loading... -
+
OA01.09 - Discussant
14:53 - 15:03 | Presenter: Jyoti Patel
- Abstract
No abstract available for this presentation
-
+
OA01.10 - Comparing Regional Results from the IASLC Global Survey on Molecular Testing in Lung Cancer (Slides Available)
15:03 - 15:13 | Presenter: Matthew Smeltzer
- Abstract
Loading... -
+
OA01.11 - Discussant: NGS Path Forward with IASLC (Slides Available)
15:13 - 15:23 | Author(s): Heather Wakelee
- Abstract
No abstract available for this presentation
-
+
PD01 - Poster Discussion Session
- Type: Poster Discussion Session
- Track:
- Presentations: 20
- Slides Available
- Coordinates: 10/11/2019, 15:45 - 16:45, Imperial Ballroom (B2 Level)
-
+
PD01.01 - Discussant: Practice Patterns: So Many Choices and Optimal Therapies (Slides Available)
15:45 - 15:55 | Author(s): Kurt Oettel
- Abstract
No abstract available for this presentation
-
+
PD01.02 - Oncologists’ Management of Advanced NSCLC: A Simulation-Based Performance Assessment
16:55 - 16:55 | Author(s): Lori Pender
- Abstract
Loading... -
+
PD01.03 - Changes in Immune Checkpoints Landscape Associated with TGF-β Induced EMT in Lung Adenocarcinoma
16:55 - 16:55 | Author(s): Imad Tarhoni
- Abstract
Loading... -
+
PD01.04 - CANOPY-A: A Phase 3 Study of Canakinumab as Adjuvant Therapy in Patients With Surgically Resected NSCLC
15:55 - 15:55 | Presenter: David R. Spigel
- Abstract
Loading... -
+
PD01.05 - CANOPY-1: Phase 3 Study of Canakinumab/Placebo+Pembrolizumab+Platinum-chemotherapy in Untreated Stage IIIB-IV NSCLC Patients
15:55 - 15:55 | Presenter: Bruce E. Johnson
- Abstract
Loading... -
+
PD01.06 - CANOPY-2: Phase 3 Study of Canakinumab Plus Docetaxel as Second/Third Line Therapy in Locally Advanced/Metastatic NSCLC
15:55 - 15:55 | Author(s): Vassiliki A. Papadimitrakopoulou
- Abstract
Loading... -
+
PD01.07 - Discussant: Novel Risk Prediction Strategies (Slides Available)
15:55 - 16:05 | Author(s): Joel Neal
- Abstract
No abstract available for this presentation
-
+
PD01.08 - Incidence and Predictors Associated With the Development of Peripheral Neuropathy in Non-small Cell Lung Cancer Patients
17:05 - 17:05 | Presenter: Jerzy Tyczynski
- Abstract
Loading... -
+
PD01.09 - Incidence and Predictors Associated with the Development of Pneumonitis in Non-small Cell Lung Cancer Patients.
17:05 - 17:05 | Presenter: Jerzy Tyczynski
- Abstract
Loading... -
+
PD01.10 - Diagnostic Non-Invasive Biopsy Can Substitute Conventional Tissue Dependent Procedures in Suspected Cases of Lung Cancer
16:05 - 16:05 | Presenter: Dadasaheb Akolkar
- Abstract
Loading... -
+
PD01.11 - Artificial Intelligence Can Detect Lung Cancer from High Resolution Microscopic Images of Conditioned Peripheral Blood
16:05 - 16:05 | Presenter: Dadasaheb Akolkar
- Abstract
Loading... -
+
PD01.12 - Discussant: Radiation in 2020 and Beyond
16:15 - 16:25 | Author(s): Kenneth Rosenzweig
- Abstract
No abstract available for this presentation
-
+
PD01.14 - Stereotactic Modulating Radiation Therapy (SMRT) for Oligo-Metastatic Non-Small Cell Lung Cancer
16:15 - 16:15 | Presenter: Joseph Kelley
- Abstract
Loading... -
+
PD01.15 - Targeting the Chemoradiation Resistance of Lung Cancers With KRAS/TP53 Co-mutations
17:15 - 17:15 | Presenter: Henning Willers
- Abstract
Loading... -
+
PD01.16 - Raman Spectroscopy and NIR Spectroscopy as Possible Aid in Localisation of Solitary Pulmonary Nodules
17:15 - 17:15 | Presenter: Jiri Votruba
- Abstract
Loading... -
+
PD01.17 - Discussant: Quality Lung Cancer Care (Slides Available)
16:15 - 16:25 | Author(s): Tim Kruser
- Abstract
No abstract available for this presentation
-
+
PD01.18 - Successful Implementation of a Free Lung Cancer Screening Program in a Rural Tertiary Care Hospital Setting.
16:25 - 16:25 | Author(s): Mathew Marsee
- Abstract
Loading... -
+
PD01.19 - Beneficial Effect of Antibiotic Use in Patients With Stage IV NSCLC Treated With Immune Checkpoint Inhibitors.
16:25 - 16:25 | Author(s): Fen Wang
- Abstract
Loading... -
+
PD01.20 - Lung Cancer Strategist Program: A Novel Care Delivery Model to Improve Timeliness of Diagnosis and Treatment
16:25 - 16:25 | Presenter: William W Phillips
- Abstract
Loading... -
+
PD01.21 - Medicaid Outcome Inequalities in Small Cell Lung Cancer
16:25 - 16:25 | Presenter: Stephen Chun
- Abstract
Loading...
-
+
P1 - Poster Viewing
- Type: Poster Session
- Track:
- Presentations: 22
- Coordinates: 10/11/2019, 16:45 - 18:00, Exhibit Hall
-
+
P1.01 - Clinical Application of Plasma miR-34b-3p and miR-302a-5p in the Diagnosis of Non-small Cell Lung Cancer
16:45 - 18:00 | Presenter: yang liu
- Abstract
Loading... -
+
P1.02 - Chemotherapy with VMAT (Volumetric Modulated Arc Therapy) Radiation Therapy for Poor Risk Stage IIIA-C NSCLC Patients
16:45 - 18:00 | Presenter: Yu Zhou
- Abstract
Loading... -
+
P1.03 - Survival Benefit of Surgically Resected Occult N2 (c-N0,1 and p-N2) Non-small-Cell Lung Cancer
16:45 - 18:00 | Presenter: Masahiko Harada
- Abstract
Loading... -
+
P1.04 - Combined Effects of HDAC Inhibitor and Metalloproteinase Inhibitor on Invasion and Growth of Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Yu Zhang
- Abstract
Loading... -
+
P1.05 - Clinical Factors Associated with Progression in Previously Treated Patients with Metastatic NSCLC on Anti-PD-1 Therapy
16:45 - 18:00 | Presenter: Megan Randall
- Abstract
Loading... -
+
P1.06 - An Overview of Lung and Breast Cancer Using the National Cancer Database
17:45 - 19:00 | Presenter: Leigh Deshotels
- Abstract
Loading... -
+
P1.07 - External Peer Review of the Western New South Wales Lung Cancer Service – A Unique Regional and Rural Australian Experience
16:45 - 18:00 | Presenter: sugamya Mallawathantri
- Abstract
Loading... -
+
P1.08 - Immunophenotyping of CD 146 Expression T Cells in Lung Cancer Patients
16:45 - 18:00 | Presenter: Ayobami Olajuyin
- Abstract
Loading... -
+
P1.09 - Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation in NSCLC
16:45 - 18:00 | Presenter: Davide Brocco
- Abstract
Loading... -
+
P1.10 - Inflammatory Signature Difference in Rural Urban and Regional Occupational Exposure in Lung Cancer
16:45 - 18:00 | Author(s): Nitika Sharma
- Abstract
Loading... -
+
P1.11 - Post-PACIFIC Trial Era: Patterns of Outcomes and Toxicities From a Single Private Institution in a Developing Country
16:45 - 18:00 | Author(s): Fl
- Abstract
Loading... -
+
P1.12 - Demographics and Survival in Malignant Pleural Mesothelioma: Analysis of SEER Data
16:45 - 18:00 | Presenter: Nwabundo Anusim
- Abstract
Loading... -
+
P1.13 - Anaplastic Lymphoma Kinase (ALK) Gene Rearrangement in Children and Young Adults with Mesothelioma
17:45 - 19:00 | Presenter: Idrees Mian
- Abstract
Loading... -
+
P1.14 - Immune Profiling Data and Mutational Status Improves Prediction of Risk of Death in Non-small Cell Lung Carcinoma
16:45 - 18:00 | Presenter: Edwin Parra
- Abstract
Loading... -
+
P1.15 - The Presence of Secondary Follicles in Early Stage Lung Adenocarcinoma Reflects Disease Burden.
16:45 - 18:00 | Presenter: Rebecca Obeng
- Abstract
Loading... -
+
P1.16 - A Study on Clinicopathological Features and Diagnostic Methods of ALK Fusion-Positive Non-small Cell Lung Cancer in Korea
16:45 - 18:00 | Presenter: Bong Kyung Shin
- Abstract
Loading... -
+
P1.17 - Comparison of Genetic Profiles of Pulmonary Sarcomatoid Carcinoma (PSC) Between Asian and Western Populations
16:45 - 18:00 | Presenter: Yijia Guo
- Abstract
Loading... -
+
P1.18 - MERTK Activation Drives Osimertinib Resistance in EGFR-mutated Non-small Cell Lung Cancer
16:45 - 18:00 | Presenter: Dan Yan
- Abstract
Loading... -
+
P1.19 - Lung Cancer Screening Initiative and Identification of Novel Blood Biomarkers for Early Detection of Lung Cancer
16:45 - 18:00 | Presenter: Shreya Deb
- Abstract
Loading... -
+
P1.20 - Metabolic Responses to Metformin in Early-stage NSCLC Treated With Definitive Radiotherapy: Results of a Phase II Trial
16:45 - 18:00 | Presenter: Stephen Chun
- Abstract
Loading... -
+
P1.21 - RNA Pathway Enrichment in Serum Based Mass Spectroscopy Prognostic Analyses.
16:45 - 18:00 | Presenter: Mary Fidler
- Abstract
Loading... -
+
P1.22 - The Lung Microbiome and Metabolome Are Altered in Lung Cancer Patients.
16:45 - 18:00 | Presenter: Frank Weinberg
- Abstract
Loading...
-
+
GS06 - Precision Medicine in Advanced Thoracic Tumors
- Type: Invited Speaker Session
- Track:
- Presentations: 8
- Slides Available
- Coordinates: 10/12/2019, 08:15 - 09:15, Imperial Ballroom (B2 Level)
-
+
GS06.01 - Introduction
08:15 - 08:18 | Presenter: Lecia Sequist
- Abstract
No abstract available for this presentation
-
+
GS06.02 - Treatment of New and Emerging Driver Mutations (Slides Available)
08:18 - 08:25 | Presenter: Paul Paik
- Abstract
No abstract available for this presentation
-
+
GS06.03 - Updates in ALK (Slides Available)
08:25 - 08:32 | Presenter: Caroline McCoach
- Abstract
No abstract available for this presentation
-
+
GS06.04 - Progression after First Line Osimertinib (Slides Available)
08:32 - 08:39 | Presenter: Lecia Sequist
- Abstract
No abstract available for this presentation
-
+
GS06.05 - Clinical Trials in MPM (Slides Available)
08:39 - 08:46 | Presenter: Hedy Kindler
- Abstract
No abstract available for this presentation
-
+
GS06.06 - SCLC - Updates (Slides Available)
08:46 - 08:52 | Presenter: Anna Farago
- Abstract
No abstract available for this presentation
-
+
GS06.07 - CNS Disease - Systemic Therapy as First Line: From a Radiation Oncology Perspective (Slides Available)
08:52 - 09:00 | Presenter: Vinai Gondi
- Abstract
No abstract available for this presentation
-
+
GS06.08 - Panel Discussion
09:00 - 09:15
- Abstract
No abstract available for this presentation
-
+
GS07 - Multidisciplinary Approaches to Diagnosis and Treatment
- Type: Invited Speaker Session
- Track:
- Presentations: 7
- Slides Available
- Coordinates: 10/12/2019, 08:15 - 09:15, Rouge (Lobby Level)
-
+
GS07.01 - Introduction
08:15 - 08:20 | Presenter: Elizabeth David
- Abstract
No abstract available for this presentation
-
+
GS07.02 - Rebiopsy after Progressive Disease, Pseudoprogression, Adjudication of Site Selection (Slides Available)
08:20 - 08:28 | Presenter: Tim Murgu
- Abstract
No abstract available for this presentation
-
+
GS07.03 - Management of Malignant Effusion (TKIs and IO) (Slides Available)
08:28 - 08:36 | Presenter: Carla Lamb
- Abstract
No abstract available for this presentation
-
+
GS07.04 - MPR Post Neo-adjuvant IO
08:36 - 08:44 | Presenter: Ignacio Wistuba
- Abstract
No abstract available for this presentation
-
+
GS07.05 - Diagnostic and Management Dilemmas in Synchronous NSCLC (Slides Available)
08:44 - 08:52 | Presenter: Elizabeth David
- Abstract
No abstract available for this presentation
-
+
GS07.06 - Ablative Radiation Therapy for Operable Disease (Slides Available)
08:52 - 09:00 | Presenter: Megan Daly
- Abstract
No abstract available for this presentation
-
+
GS07.07 - Panel Discussion
09:00 - 09:15
- Abstract
No abstract available for this presentation